BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36149250)

  • 1. Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies.
    Hale MM; Medina SH
    Mol Pharm; 2022 Dec; 19(12):4453-4465. PubMed ID: 36149250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination strategies for antithrombotic biomaterials: an emerging trend towards hemocompatibility.
    Ashcraft M; Douglass M; Chen Y; Handa H
    Biomater Sci; 2021 Apr; 9(7):2413-2423. PubMed ID: 33599226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of thrombolytic therapy.
    Curzen N; Haque R; Timmis A
    Intensive Care Med; 1998 Aug; 24(8):756-68. PubMed ID: 9757918
    [No Abstract]   [Full Text] [Related]  

  • 6. Historical overview of antithrombotic and thrombolytic therapy.
    Sharma GV
    Am J Med; 1987 Aug; 83(2A):2-5. PubMed ID: 3307400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptokinase--the drug of choice for thrombolytic therapy.
    Kunamneni A; Abdelghani TT; Ellaiah P
    J Thromb Thrombolysis; 2007 Feb; 23(1):9-23. PubMed ID: 17111203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation in thrombolytic therapy: importance and future perspectives].
    Harenberg J; Heene DL
    Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic Enzymes of Microbial Origin: A Review.
    Diwan D; Usmani Z; Sharma M; Nelson JW; Thakur VK; Christie G; Molina G; Gupta VK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy strategies for acute coronary syndrome and after coronary interventions. Antiplatelet agents and anticoagulants].
    Divchev D; Nienaber C; Ince H
    Internist (Berl); 2011 Nov; 52(11):1292-300. PubMed ID: 21922225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulants and thrombolytics: what's the difference?
    Workman ML
    AACN Clin Issues Crit Care Nurs; 1994 Feb; 5(1):26-35. PubMed ID: 7767794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and prevention of thrombotic episodes with hereditary thrombophilia].
    Bauer KA
    Vestn Ross Akad Med Nauk; 1997; (1):32-7. PubMed ID: 9064020
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic and clinical characteristics of thrombolytic agents.
    Deitcher SR; Jaff MR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S25-33. PubMed ID: 15112713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized antithrombotic therapy.
    Lüscher TF; Steffel J
    Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic Enzymes for Thrombolytic Therapy.
    Kumar SS; Sabu A
    Adv Exp Med Biol; 2019; 1148():345-381. PubMed ID: 31482506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of thrombosis and anticoagulation post Fontan surgery.
    Attard C; Huang J; Monagle P; Ignjatovic V
    Thromb Res; 2018 Dec; 172():204-213. PubMed ID: 29685556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.